1-(Cyclopropylcarbonyl)piperazine Hydrochloride CAS 1021298-67-8 Ubunyulu ≥99.0% Olaparib Intermediate Factory

Inkcazelo emfutshane:

Igama: 1-(Cyclopropylcarbonyl)piperazine Hydrochloride

I-CAS: 1021298-67-8

Ubunyulu: ≥99.0%

Imbonakalo: Umgubo oMhlophe

Phakathi kwe-Olaparib (CAS: 763113-22-0) PARP-Inhibitor

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

I-Olaparib kunye nabaPhakathi abaNxulumeneyo:
Olaparib CAS 763113-22-0
2-Fluoro-5-Formylbenzonitrile CAS 218301-22-5
I-2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid CAS 763114-26-7
1-(Cyclopropylcarbonyl)piperazine Hydrochloride CAS 1021298-67-8
3-Oxo-1,3-Dihydroisobenzofuran-1-Ylphosphonic Acid CAS 61260-15-9

Iipropati zeMichiza:

Igama leMchiza	1-(Cyclopropylcarbonyl)piperazine Hydrochloride
Inombolo yeCAS	1021298-67-8
Inombolo yeCAT	RF-PI452
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C8H14N2O·HCl
Ubunzima beMolekyuli	190.67
Indawo yokunyibilika	175.0 ukuya 179.0℃
Ukunyibilika	Inyibilika emanzini
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe
Ubunyulu	≥99.0%
Ukufuma (KF)	≤0.50%
Ukungacoceki Okukodwa	≤0.50%
Ukungcola ngokupheleleyo	≤1.0%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Pharmaceutical Intermediate

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, Igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-1-(Cyclopropylcarbonyl) i-piperazine Hydrochloride (CAS: 1021298-67-8) isetyenziswe njenge-pharmaceutical intermediate.Ingasetyenziswa njengendawo ephakathi ye-Olaparib (CAS: 763113-22-0).I-Olaparib iyi-inhibitor enamandla kuzo zombini i-PARP-1 kunye ne-PARP-2 kwaye ivakalelwa kakhulu kwiiseli ze-KB2P ngenxa yokunyanzeliswa kokulungiswa kwe-base excision nge-PARP inhibition.I-Olaparib yamkelwa kwi-2014 yi-FDA yokunyanga umhlaza we-ovarian ophezulu.